Quantum BioPharma Ltd. is trading at $4.72 (-10.10%) following an FDA clinical hold on its Lucid-MS IND application, which has significantly weighed on investor sentiment.
- The regulatory setback for the lead multiple sclerosis candidate extends a steep downward trend, following a -23.47% drop on June 1, 2026.
- Shares are currently trading well below recent closing prices, underperforming broader U.S. markets which are trending slightly higher.